Enbrel Sureclick (etanercept) is a medication that belongs to a class of drugs called tumor necrosis factor (TNF) inhibitors. It is used to treat various autoimmune diseases such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and plaque psoriasis.
How Enbrel Sureclick Works:
Enbrel Sureclick works by blocking the activity of TNF, which is a protein that contributes to the inflammation and joint damage that occurs in autoimmune diseases. By reducing the activity of TNF, Enbrel Sureclick helps to reduce the inflammation and joint damage associated with these conditions.
Dosage and Administration:
Enbrel Sureclick is available in a pre-filled autoinjector device. The recommended dose for adults is 50 mg per week for rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. For plaque psoriasis, the recommended dose is 50 mg twice weekly for the first 12 weeks, followed by 50 mg once weekly thereafter.
Enbrel Sureclick should be injected subcutaneously (under the skin), typically in the thigh or abdomen. Patients can self-administer Enbrel Sureclick after receiving proper training from their healthcare provider. It is important to follow the instructions for use provided with the medication and to rotate injection sites to prevent irritation.
As with any medication, Enbrel Sureclick can cause side effects. Common side effects may include injection site reactions (such as redness, swelling, or itching), upper respiratory infections, headache, and nausea. Serious side effects may include infections, allergic reactions, and autoimmune disorders. It is important to notify your healthcare provider if you experience any side effects while taking Enbrel Sureclick.
Before starting Enbrel Sureclick, patients should inform their healthcare provider of any medical conditions they have, as well as any medications or supplements they are taking. Enbrel Sureclick should not be used by patients with active infections or a history of tuberculosis. It is important to inform your healthcare provider if you have been exposed to tuberculosis or if you have any signs of infection while taking Enbrel Sureclick.
Enbrel Sureclick can also increase the risk of developing certain types of cancer, particularly lymphoma. Patients should discuss their risk factors for cancer with their healthcare provider before starting Enbrel Sureclick.
Enbrel Sureclick is a medication used to treat autoimmune diseases such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and plaque psoriasis. It works by blocking the activity of TNF, which reduces inflammation and joint damage. Enbrel Sureclick is administered subcutaneously once a week for most conditions and twice a week for plaque psoriasis. Patients should be aware of the potential side effects and should notify their healthcare provider if they experience any symptoms. Enbrel Sureclick should be used with caution in patients with a history of tuberculosis or cancer.
DISCLAIMER: The information provided here is intended to be a general overview of Enbrel Sureclick (etanercept) and is not intended to replace professional medical advice. This information is provided "as is" and without warranties of any kind, whether expressed or implied. The use of Enbrel Sureclick should only be done under the guidance and supervision of a healthcare professional. Always consult with your healthcare provider before starting or stopping any medication, and never disregard professional medical advice or delay in seeking it because of something you have read on this website. The manufacturer of Enbrel Sureclick may change the product label or warnings over time, so it is important to always refer to the latest product information and consult with your healthcare provider regarding any questions or concerns you may have about Enbrel Sureclick.